Trial Profile
Does reduction of disease activity influence endothelial function in patients with rheumatoid arthritis? (An open label pilot study with rituximab)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 Apr 2014
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Biomarker; Pharmacodynamics
- 21 Mar 2012 New trial record